NortanshinoneCAS# 97399-70-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 97399-70-7 | SDF | Download SDF |
PubChem ID | 10062187.0 | Appearance | Powder |
Formula | C17H12O4 | M.Wt | 280.28 |
Type of Compound | Terpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1-methyl-8,9-dihydro-7H-naphtho[1,2-g][1]benzofuran-6,10,11-trione | ||
SMILES | CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4=O | ||
Standard InChIKey | YUFZXVOYNSJPSJ-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C17H12O4/c1-8-7-21-17-11-6-5-9-10(3-2-4-12(9)18)14(11)16(20)15(19)13(8)17/h5-7H,2-4H2,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Nortanshinone Dilution Calculator
Nortanshinone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.5679 mL | 17.8393 mL | 35.6786 mL | 71.3572 mL | 89.1965 mL |
5 mM | 0.7136 mL | 3.5679 mL | 7.1357 mL | 14.2714 mL | 17.8393 mL |
10 mM | 0.3568 mL | 1.7839 mL | 3.5679 mL | 7.1357 mL | 8.9197 mL |
50 mM | 0.0714 mL | 0.3568 mL | 0.7136 mL | 1.4271 mL | 1.7839 mL |
100 mM | 0.0357 mL | 0.1784 mL | 0.3568 mL | 0.7136 mL | 0.892 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Prosaikogenin A
Catalog No.:BCX1520
CAS No.:99365-21-6
- Resveratrol-4'-O-(6"-galloyl)-β-D-glucopyranoside
Catalog No.:BCX1519
CAS No.:928340-97-0
- Norfuronol
Catalog No.:BCX1518
CAS No.:19322-27-1
- dehydrotomatine
Catalog No.:BCX1517
CAS No.:157604-98-3
- Debenzoylpaeoniflorgenin
Catalog No.:BCX1516
CAS No.:1429403-79-1
- Paeoniflorgenin
Catalog No.:BCX1515
CAS No.:697300-41-7
- Synigrin
Catalog No.:BCX1514
CAS No.:534-69-0
- Rhetsinine
Catalog No.:BCX1513
CAS No.:526-43-2
- Smilagenin acetate
Catalog No.:BCX1512
CAS No.:4947-75-5
- Lycoramine Hydrobromide
Catalog No.:BCX1511
CAS No.:89505-76-0
- Isocoptisine acetate
Catalog No.:BCX1510
CAS No.:30426-66-5
- Isoemetine hydrobromide
Catalog No.:BCX1509
CAS No.:21026-77-7
- Acetylseneciphylline N-oxide
Catalog No.:BCX1522
CAS No.:123844-00-8
- Dahurinol
Catalog No.:BCX1523
CAS No.:38908-87-1
- Luteolin 7-sulfate
Catalog No.:BCX1524
CAS No.:56857-57-9
- Bitalgenin
Catalog No.:BCX1525
CAS No.:2192-25-8
- (±)-Dihydrokaempferol
Catalog No.:BCX1526
CAS No.:104486-98-8
- Isoescin Ie
Catalog No.:BCX1527
CAS No.:1613506-28-7
- Dihydroactindiolide
Catalog No.:BCX1528
CAS No.:15356-74-8
- 4-Vinylphenol
Catalog No.:BCX1529
CAS No.:2628-17-3
- d-Epigalbacin
Catalog No.:BCX1530
CAS No.:84709-25-1
- (+)-Dehydroabietic acid
Catalog No.:BCX1531
CAS No.:1231-75-0
- 31-Norlanostenol
Catalog No.:BCX1532
CAS No.:16910-39-7
- Mexoticin
Catalog No.:BCX1533
CAS No.:18196-00-4
[Analysis of lipophilic components of Salvia miltiorrhiza roots and S. yunnanensis roots by UPLC and LC-MS/MS].[Pubmed:30989985]
Zhongguo Zhong Yao Za Zhi. 2019 Mar;44(6):1208-1215.
Fingerprints of lipophilic components in the roots of Salvia miltiorrhiza and S.yunnanensis were analyzed by UPLC-DADand UPLC coupled with mass spectroscopy to evaluate the differences and similarities of the lipophilic components in the two kinds of herbs.The UPLC analysis of 18 batches of S.miltiorrhiza and 16 batches of S.yunnanensis was performed on a 25℃Thermo Accucore C_(18)column(2.1 mmx100 mm,2.6mum)by Shimadzu LC-20AD;mobile phase was 0.026%phosphoric acid(A)-acetonitrile(B)with gradient elution;flow rate was 0.4 m L.min~(-1);detection wavelength was set at 270 nm;injection volume was 2muL.The molecular structures of the lipophilic components were analyzed on a 25℃Thermo Accucore C_(18)column(2.1 mmx100 mm,2.6mum)by Thermo U3000 UPLC Q Exactive Orbitrap LC-MS/MS with a mobile phaseconsisting of 0.1%formic acid water(A)and 0.1%formic acidacetonitrile(B).The mass spectrometry was acquired in positive modes using ESI.There are 10 common peaks in the lipophilic components of S.miltiorrhiza.The similarity between the 16 batches of S.miltiorrhiza and their own reference spectra was greater than 0.942,and the average similarity was 0.973.There are 12 common peaks in the lipophilic components of S.yunnanensis.The similarity between the 18 batches of S.yunnanensis and their own reference spectra was greater than 0.937,and the average similarity was 0.976.The similarity between the reference chromatograms of S.miltiorrhiza and S.yunnanensis was only 0.900.There are three lipophilic components in S.yunnanensis,which are not found in S.miltiorrhiza,and one of which isalpha-lapachone.There is a lipophilic component in S.miltiorrhiza not found in S.yunnanensis,which may be miltirone.The two herbs contain 8 common lipophilic components including dihydrotanshinoneⅠ,cryptotanshinone,tanshinoneⅠ,tanshinoneⅡ_A,Nortanshinone in which the content of tanshinoneⅡ_A,dihydrotanshinoneⅠand cryptotanshinone of S.yunnanensisis significantly lower than that of S.miltiorrhiza(P<0.01),and the contents of tanshinoneⅠand Nortanshinone are significantly lower than that of S.miltiorrhiza too(P<0.05).There are significant differences in the types and contents of lipophilic components between the roots of S.miltiorrhiza and S.yunnanensis,and the similarity between the fingerprints of interspecies is much lower than that between the same species.Therefore,the roots of S.miltiorrhiza and S.yunnanensis are two kinds of herbs which are quite different in chemical compounds and compositions.
[Chemical studies of Salvia miltiorrhiza f. alba].[Pubmed:1957662]
Yao Xue Xue Bao. 1991;26(3):209-13.
Fourteen constituents were isolated from the roots of Salvia miltiorrhiza f. alba. Two of them were new compounds and were named 1,2,15,16-tetrahydrotanshiquinone (I) and tanshinaldehyde (II). The others were identified as Ro-090680 (III), dihydroisotanshone I (IV), danshexinkun B (V), miltirone (VI), Nortanshinone (VII), hydroxytanshinone II-A (VIII), tanshinone I (IX), dihydrotanshinone I (X), tanshinone II-A (XI), cryptotanshinone (XII), methylenetanshiquinone (XIII), methyltanshinonate (XIV), I and III showed inhibitory activity against P388 Leukemia cell in vitro. III was reported to be a potent inhibitor of rabbit platelet aggregation induced by collagen.